Omics and Network-based Approaches in Understanding HD Pathogenesis
Open Access
- 29 February 2024
- book chapter
- Published by IntechOpen
Abstract
Huntington’s Disease (HD) is a rare, progressive neurodegenerative disease caused by CAG repeat expansion in the Huntingtin gene. HD is an incurable disease; therefore, there is a growing need for effective therapeutic treatments and candidate biomarkers for prognosis and diagnosis of HD. Technological advancements over the past couple of years, have led to high-throughput experiments and omics data. The use of System Bioinformatics (SB) approaches, allows for the integration of information across different -omics, this can clarify synergistic relationships across biological molecules, resulting in complex biological networks. SB and network-based approaches, are able to shed light on the potential interactions of genes, proteins, metabolites and pathways participating in HD pathogenesis and how dysregulation of these biological entities, can affect age on onset, disease severity and progression. Moreover, −omics data analysis and network-based approaches can provide better understanding how these biological molecules interact with each other and provides potential drug targets and biomarkers that can be used to treat HD or delay symptom onset; therefore, opening the door towards precision medicine. The aim of the following chapter, is to discuss the most popular -omics related to HD research, and the growing popularity of single cell analysis, repositories and software available for bulk and single cell analysis. In addition, network-based approaches regarding HD will also be mentioned.Keywords
This publication has 143 references indexed in Scilit:
- Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington’s diseaseFEBS Open Bio, 2021
- Enhanced cerebral branched-chain amino acid metabolism in R6/2 mouse model of Huntington’s diseaseCellular and Molecular Life Sciences, 2019
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohortAnnals of Clinical and Translational Neurology, 2018
- Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samplesMetabolomics, 2016
- The Gene Expression Omnibus Database2016
- A systems‐level “misunderstanding”: the plasma metabolome in Huntington's diseaseAnnals of Clinical and Translational Neurology, 2015
- Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer’s Disease, Huntington’s Disease and Multiple SclerosisNeurochemical Research, 2012
- Mechanism(s) of Alteration of Micro RNA Expressions in Huntington’s Disease and Their Possible Contributions to the Observed Cellular and Molecular Dysfunctions in the DiseaseNeuroMolecular Medicine, 2012
- Metabolomic Data Processing, Analysis, and Interpretation Using MetaboAnalystCurrent Protocols in Bioinformatics, 2011
- The PeptideAtlas Project2009